Who owns Synapse Medicine?

Synapse Medicine is currently owned by Korelya Capital, through K-Fund II, since 2022.

When did Korelya Capital acquire Synapse Medicine?

Korelya Capital acquired Synapse Medicine in 2022 (active for 4 years).

Home/Companies/Healthcare/Synapse Medicine

Synapse Medicine

Healthcare·

France·Active·4yr hold

Synapse Medicine is a healthtech company, headquartered in France.

Entry

2022

Hold

4yr

Status

Active

Est. EV

–

Most recent investor

Korelya Capital

2 ownership periods

Key facts

HQFrance

SectorHealthtech

French clinical AI platform for medication safety and prescribing; Korelya led Series B March 2022 USD 28M round.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from K-Fund II

Other portfolio companies in the same fund.

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.

Last updated April 2026 · Sourced from public filings